UnitedHealth subsidiary Emisar Pharma Services was issued a compulsory order by the Federal Trade Commission, the agency said in a statement.
- Will require Emisar to provide information and records on business practices
- It’s part of ongoing study on pharmacy benefit managers and their impact on accessibility and affordability of prescription drugs
- Order to Emisar is “substantially similar” to orders recently issued to Zinc Health Services and Ascent Health Services
- NOTE:
US Probing Drug Middlemen’s New Units That Negotiate Price Cuts
To view the source of this information, click
To contact the reporter on this story:
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.